Erratum to: Effect of Therapeutic Interventions on Health-related Quality of Life in Parkinson’s Disease
Erratum to: Heinz Reichmann, Pablo Martínez-Martin and Fabrizio Stocchi. Effect of Therapeutic Interventions on Health-related Quality of
Life in Parkinson’s Disease. European Neurological Review, 2014;9(1):19–26
The authors of the above-mentioned paper would like to make the following adjustment to their article.
The title of Table 1 on the second page should read “Level of Evidence Supporting Early Parkinson’s Disease Drugs Based on Efficacy Against Motor Symptoms”.
The authors thank Touch Medical Media for publishing this correction.
Share this Article
Related Content In Movement Disorders
A Bird in the Hand: A Neurologist’s Guide to Efficient Tweeting in the Age of Social Media
touchREVIEWS in Neurology 2022;18(2):76–80 DOI: https://doi.org/10.17925/USN.2022.18.2.76
The surge in social media use seems to have become a sign of our times. Social media has ramified into not only our personal lives but, importantly, also our professional lives and will continue to do so in the future.1–4 At the same time, more neurologists resorted to online learning modalities, including podcasts and social media […]
Assessment and Treatment of Myoclonus: A Review
touchREVIEWS in Neurology 2022;18(1):38–41 DOI: https://doi.org/10.17925/USN.2022.18.1.38
Myoclonus is defined as a sudden, brief, lightning-like muscle contraction.1 It was first described by Friedreich in 1881 when he detailed sharp jerks involving the bulk of a full muscle without marked limb or joint movement and called it paramyoclonus multiplex.2 Myoclonus may be described as either positive myoclonus (increase in contraction activity) or negative myoclonus (inhibition […]
Emerging Therapies in Friedreich’s Ataxia: A Review
touchREVIEWS in Neurology. 2022;18(1):32–7 DOI: https://doi.org/10.17925/USN.2022.18.1.32
It has been nearly 160 years since Friedreich’s ataxia (FRDA) was clinically recognized and described1 and 25 years since the FXN gene was discovered.2 Despite this, there are still no approved therapies for FRDA. FRDA is an autosomal, recessively inherited, neurodegenerative disease that typically presents in childhood and results in progressive gait and limb ataxia, with the extraneural features […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!